Uganda {malaria case study}
- Created by: bumpybug
- Created on: 03-01-23 20:31
View mindmap
- Uganda {malaria case study}
- Statistics
- Uganda's Ministry of Health says that malaria kills 5,000 people per year.
- Despite its prevalence, only 5% of Uganda's health budget is contributed to dealing with malaria.
- The new 'R21' malaria vaccine, developed by the University of Oxford, could reduce deaths by 70% by 2030 and eradicate malaria by 2040.
- Background information
- Uganda is located in Central Africa, directly on the equator.
- In 2009, the first malaria drug factory in Uganda was opened. Not only does it increase production of anti-malarial drugs and lower costs, but also provides jobs for locals.
- Mitigation methods
- Strategies used in Uganda to tackle malaria include: improving drainage and irrigation, insecticides and nets.
- Medicins Sans Frontiers aims to make ACTs (the main anti-malarial drug) free and available to everyone living in Uganda.
- However, around 75% of ACTs are intercepted and sold on the black market at unaffordable prices.
- ITNs (insecticide-treated nets) and LLINs (long-lasting insecticide-impregnated nets) are commonly used in Uganda as a cheaper preventative method.
- Effects on Uganda's economy
- It is estimated that malaria-related health expenditures and lost productivity costs the African economy around $8 billion per year.
- Malaria deters foreign investment and tourism in Uganda.
- Malaria can decrease GDP by as much as 1.3% in countries with high levels of admission.
- Statistics
Comments
No comments have yet been made